Status:
UNKNOWN
Injections in the Diagnosis and Treatment of Lumbar Facet Syndrome
Lead Sponsor:
Complejo Hospitalario Universitario de Granada
Conditions:
Facet Joint Pain
Facet Syndrome of Lumbar Spine
Eligibility:
All Genders
18-79 years
Phase:
NA
Brief Summary
In suspected facet joints pain, it is recommended to perform nerve blocks to establish the diagnosis with positive results being and indicator of successful of most permanent treatment of facet pain b...
Detailed Description
Facet joint pain is considered as a nonspecific cause of spinal pain with an estimated prevalence of 12-61% of the population. At present, there are no unanimous clinical criteria to achieve and accur...
Eligibility Criteria
Inclusion
- 1- Lumbar facet syndrome diagnosed by the referring specialist: Rehabilitation, Traumatology or Neurosurgery 2 -Mechanical low back pain that increases with rotation and flexion-extension, without radicular irradiation.
- 3- failure of conservative treatment (pharmacological and physical therapy). 4-Symptoms present more than 3 months
Exclusion
- Previous back surgery and other ablative treatments.
- Contraindication for the use of corticosteroid or local anesthetic.
- Uncontrolled acute or chronic medical illness.
- Pregnancy or lactation.
- Presence of inflammatory arthropathy or neuropathy.
- Wounds or skin lesions in the area.
- Diabetes mellitus.
- Psychiatric disorders
- Refusal to participate in the study.
- Demonstration by imaging techniques of other causes that could justify the symptomatology.
Key Trial Info
Start Date :
August 15 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 15 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03871192
Start Date
August 15 2018
End Date
August 15 2020
Last Update
March 15 2019
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Complejo Hospitalario Universitario Granada
Granada, SPA, Spain, 18014
2
Hospital Neuro-Traumatologia
Granada, Spain, 1800314